This study showed that patients taking 75mg of Olpasiran previously every 12 weeks presented a 40–50% reduction in LP(a)
The inspection classification was determined by the agency as Voluntary Action Indicated
This approval has come from the company's finished dosage form manufacturing facility
Robots make it to the healthcare conference panel, reflecting the future potential of technology
Amneal’s site in Matoda is one of the company’s 12 pharmaceutical manufacturing facilities
Dr. Laurent Leksell, Elekta’s Founder and Chairman of the Board, and IAEA’s Director General, Dr. Rafael Mariano Grossi meet in Stockholm to discuss reducing the global cancer burden
The three-week travel campaign is aimed at spreading awareness about infertility and making Karnataka infertility-free
The 100 surgeries conducted using robotic technology span various intricate procedures in the fields of Urology, Liver Transplantation, GI surgery, Cardiac surgeries and Gynaecology
First PARP inhibitor approved in Japan to demonstrate clinically meaningful benefits in combination with a new hormonal agent
India will account for about 18% of the Asia-Pacific (APAC) MRI systems market in 2023
Subscribe To Our Newsletter & Stay Updated
